Insulin Glargine (U-300) Pens and Skyrizi Injection
Determining the interaction of Insulin Glargine (U-300) Pens and Skyrizi Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Risankizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-300) Pens-Skyrizi topical
- Insulin Glargine (U-300) Pens-Sleep Aid
- Insulin Glargine (U-300) Pens-Sleep Aid Tablets
- Insulin Glargine (U-300) Pens-Sleepinal
- Insulin Glargine (U-300) Pens-Slo-Niacin
- Insulin Glargine (U-300) Pens-Slow Fe
- Skyrizi Injection-Insulin glargine and lixisenatide
- Skyrizi Injection-Insulin glargine and lixisenatide Subcutaneous
- Skyrizi Injection-Insulin glargine, recombinant Subcutaneous
- Skyrizi Injection-Insulin glulisine
- Skyrizi Injection-Insulin Glulisine (Cartridges and Pens)
- Skyrizi Injection-Insulin Glulisine (Vials)